Download PDF
Thromb Haemost 1997; 78(01): 191-194
DOI: 10.1055/s-0038-1657524
Pathogenesis of atherosclerosis: a l997 update
Schattauer GmbH Stuttgart

Crossroads of L-Arginine/Arachidonate Metabolism

Ryszard J Gryglewski
1   Jagiellonian University Medical College, Cracow, Poland
,
Ryszard Korbut
1   Jagiellonian University Medical College, Cracow, Poland
,
Wojciech Uracz
1   Jagiellonian University Medical College, Cracow, Poland
,
Tadeusz Malinski
2   Department of Chemistry, Oakland University, Rochester, Ml, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Gryglewski RJ, Chlopicki S, Swiês J, Niezabitowski P. Prostacyclin, nitric oxide and atherosclerosis. Ann NY Acad Sci 1995; 748: 195-207
    PubMedGoogle Scholar
  • 2 Giyglewski RJ. Interactions between endothelial secretogogues. Ann Med 1995; 27: 421-427
    CrossrefPubMedGoogle Scholar
  • 3 Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukocyte Biol 1994; 56: 759-768
    CrossrefPubMedGoogle Scholar
  • 4 Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respirat Crit Care Med 1995; 151: 1250-1254
    PubMedGoogle Scholar
  • 5 Szabó C, Zingarelli B, O’Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Nat Acad Sci USA 1996; 93: 1753-1758
    CrossrefPubMedGoogle Scholar
  • 6 Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487
    CrossrefPubMedGoogle Scholar
  • 7 Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. TNF-induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995; 269: L551-L559
    PubMedGoogle Scholar
  • 8 Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309-316
    CrossrefPubMedGoogle Scholar
  • 9 Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxy-nitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylate cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 1995; 270: 17355-17360
    CrossrefPubMedGoogle Scholar
  • 10 Kanner J, Harel S, Granit R. Nitric oxide an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27: 46-49
    CrossrefPubMedGoogle Scholar
  • 11 Zou M-H, Ullrich V. Peroxinitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine prostacyclin synthase. FEBS Lett 1996; 382: 101-104
    CrossrefPubMedGoogle Scholar
  • 12 Salvemini D, Misko TP, Masferrer L, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244
    CrossrefPubMedGoogle Scholar
  • 13 Marotta P, Sautebin L, Di RosaM. Modulation of the induction of nitric oxide synthase by eicosanoid in the murine macrophage cell line J774 cells. Br J Pharmacol 1992; 107: 640-641
    CrossrefPubMedGoogle Scholar
  • 14 Stamler JS, Vaughan DE, Loscalzo J. Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin Ej and nitroglycerin. Circ Res 1989; 65: 796-804
    CrossrefPubMedGoogle Scholar
  • 15 Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with perpheral arterial disease. Wien Klin Wochenschr 1993; 105: 07-11
    PubMedGoogle Scholar
  • 16 Chlopicki S, Gryglewski RJ. Nitric oxide is a major mediator in reactive hyperaemia evoked by a brief coronary occlusion in the guinea pig heart. Eur J Pharmacol 1993; 241: 117-120
    CrossrefPubMedGoogle Scholar
  • 17 Szczeklik A, Giyglewski RJ. Low-density lipoproteins (LDL) are carriers for lipid peroxides and invalidate prostacyclin (PGI2) biosynthesis in arteries. Artery 1980; 07: 488-492
    PubMedGoogle Scholar
  • 18 Yang X, Cai B, Sciacca RR, Cannon JP. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Cir Res 1994; 74: 318-328
    CrossrefPubMedGoogle Scholar
  • 19 Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994; 90: 35-44
    CrossrefPubMedGoogle Scholar
  • 20 Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett 1993; 334: 170-174
    CrossrefPubMedGoogle Scholar
  • 21 Parratt JR. An introduction and an overview. In Schlag G, Redl H. (eds) Nitric Oxide and Cardiovascular Dysfunction in Sepsis and Endotoxaemia. Springer Verlag; Belin, Heidelberg, New York: 1995: 01-29
    Google Scholar
  • 22 Szabó C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischaemia-reperfusion injury. Shock 1996; 06: 01-10
    CrossrefPubMedGoogle Scholar
  • 23 Wang WW, Jenkinson CP, Griscawage JM, Kern RM, Arabolos NS, Byrns RE, Cederbaum SD, Ignarro LJ. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995; 210: 1009-1016
    CrossrefPubMedGoogle Scholar
  • 24 Kilboum RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-1138
    CrossrefPubMedGoogle Scholar
  • 25 Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-39
    CrossrefPubMedGoogle Scholar
  • 26 Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142-147
    CrossrefPubMedGoogle Scholar
  • 27 Pastor C, Teisseire B, Vicaut E, Payen D. Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22: 465-469
    CrossrefPubMedGoogle Scholar
  • 28 Mulder MF, van LambalgenAA, Huisnab E, Visser JJ, and den BosGC, Thijs LG. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 1994; 266: H1558-H1564
    PubMedGoogle Scholar
  • 29 Statman R, Cheng W, Cunningham JN, Henderson JL, Damiani P, Siconolfi A, Rogers D, Horovitz JK. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenataion. J Surg Res 1994; 57: 93-98
    CrossrefPubMedGoogle Scholar
  • 30 Hutcheson IR, Whittle BJ, Boughton SmithNK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-820
    CrossrefPubMedGoogle Scholar
  • 31 Shultz PJ, Raij L. Endogenously synthetized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725
    CrossrefPubMedGoogle Scholar
  • 32 Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994; 266: G1004-G1010
    PubMedGoogle Scholar
  • 33 Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91: 12472-12476
    CrossrefPubMedGoogle Scholar
  • 34 Malinski T, Czuchajowski L. Nitric oxide measurement by electro-chemical methods. In Feelisch M, Stamler JS. (eds) Methods of Nitric Oxide Research Wiley, Chichester: 1996: 319-339
    Google Scholar
  • 35 Gryglewski RJ, Szczeklik A, Korbut R, Swies J, Musial J, Krzanowski M, Maga P. The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel — a new thromboxane synthase inhibitor. Wien Klin Wochenschr 1995; 107: 283-289
    PubMedGoogle Scholar
  • 36 Casals-Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol 1987; 135: 117-122
    CrossrefPubMedGoogle Scholar
  • 37 Gryglewski RJ, Wolkow PP, Uracz W, Janowska E, Bartus JB, Balbatun O, Hatrik S, Patton S, Malinski T. Protective role of pulmonary nitric oxide in acute phase of endotoxaemia in rats. In preparation
    PubMedGoogle Scholar
  • 38 Rossoni G, Sala A, Berti F, Testa T, Buccelati C, Molta C, Müller-Pedinghaus R, Maclouf J, Folco G. Myocardial protection by the leukotriene synthesis inhibitor BAY X 1005: importance of transcellular biosynthesis of cysteinyl-leukotriens. J Pharm Exp Ther 1996; 276: 335-341
    PubMedGoogle Scholar
  • 39 Uhlig S, Wolin L, Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol 1994; 77: 262-269
    CrossrefPubMedGoogle Scholar